Check out the 8-K on April 16th - half way down the page...it's all there. Stock for the leadership is they hit their numbers. $88.06 is the target.
Thanks to both of you. So, it shows that to take such a position in HZNP after such a terrific climb really gives strength to that specific point in this climb...why would someone buy (with their background and knowledge) at the top? Ok, I am only stating the obvious but it's sometime good to do that.
What I meant was: how long does it usually take to plan, negotiate, implement and close a deal like this? 2 weeks, 2 months - what time frame? The reason I ask is that if it's a longer term of developing - it shows the quality of the company. HZNP's price was most likely considerably less than where it is now.
Statement and question: This is so similar to the last offering - you need to think about how much time it takes to put something like this together - interaction with the buyer would most likely be well be for the $28.25 share price is in view. If this is true...it shows the strength of this company / stock. Someone wanted a nice piece for a premium.
Mike, how long does it take for a typical agreement like this take - from initiation to end? (I'm afraid of the answers - could it be 3 to 5 days? LOL).
JMJ - someone must have seen the 8-K and finally understood what the 12 million will be used for...it's somewhat predictable. As I've said before with this company: Look at the past to see the future...it's coming pretty fast. IMHO
TW knew how the "offering" would be played in after hours and tomorrow to trip the stop loses...but look at how he had an 8-K out right after the bell with that impressive information regarding the growth of the basic products that started this company. Read between the lines...IMHO
Weekly prescriptions of our primary care products grew significantly during the first quarter of 2015. Despite being placed on certain formulary exclusion lists beginning on January 1, 2015, during the first 12 weeks of 2015, DUEXIS�(ibuprofen/famotidine) weekly prescriptions rose 42% and VIMOVO� (naproxen/esomeprazole magnesium) weekly prescriptions rose 26%. Compared to the first 12 weeks of 2014, DUEXIS weekly prescriptions rose 55% and VIMOVO weekly prescriptions rose 9%. With respect to PENNSAID� (diclofenac sodium topical solution) 2% w/w, during the first 12 weeks of 2015, weekly prescriptions grew each week, representing a 353% increase during the period. We also continued to increase Prescriptions-Made-Easy ("PME") activation for our primary care products in the first quarter of 2015, with the percentage of prescriptions filled through PME rising to 58%, 44% and 56% for DUEXIS, VIMOVO and PENNSAID 2%, respectively, for the week ended March 27, 2015.
JCBrown, obiviously I am not an expert in the legal realm - specifically these type of lawsuits. The point I think needs to be made and considered is that the price of Hyperion on June 5, 2014 was $29.75. By 12-1-2014 it had fallen to $20.40. From that point on it climbed almost straight up to $43.56 on March 26th, four days prior to the announcement of the sale. It certainly looks like Hyperion received a significant premium for their stock - well over 100% within 4 months. It would be interesting to know exactly when Horizon spoke with the Hyperion management regarding a buyout? I understand how adding a few "Hundred Million" might sweeten the deal and make this disappear but it appears they already make a chunk...maybe it's expected they make the rest?
I'll be glad to see this one over and moving foreword.
Thanks Soflaturtle - great update. I love the tips of the skis part too....I remember trying to learn to ski back in the day...it was the most important part of skiing a double black diamond. Once you experience that moment in the life of skiing...it all changes for the good.
TW is getting out over his skis too - in the March 27th 8-K (sounds like a ski company) that he has set the goal for HZNP management to hit $88.06 target share price.
Look on HZNP's website under - Financial Information - SEC - March 27th - Look half way down the page where the heading says: Performance-Based Share Unit Grants.
Can you imagine the EPS at that time? It will be interesting to follow. This goal puts the Market Cap on track with what company? It's a style of music you hear in New Orleans a lot.
You once again have to give credit where credit is due: Geringerart found and commented about it.
Back to my skiing days, I took a wonderful ski class at Copper Mountain, CO. For $25 you spent 2 hours with an Olympic skier. You told them what you wanted to improve on. What a lesson that was. You know, I see this board like that day. There is so much information shared and it helps us all.
Thank you and Happy Easter
Correct - for those that want to know it all - it was $88.06 - go to the March 27th's 8-K (listed on HZNP's website under - Financial Information - SEC ) Look half way down the page where the heading says:Performance-Based Share Unit Grants.
You once again have to give credit where credit is due: Geringerart found this and commented.
Hey rja - I think we all need to understand how to interpret numbers! The number 7 is across from the "Number of Brokers" giving price targets. I never thought of taking the number of brokers recommending the stock price and equating it to an actual price! Hey, we need 73 more brokers to give a rating so that the stock hits $80 per TWs challenge to his management. It's so simple...we make it too hard!!!!
I believe we all need to take a good look at the Zacks and Cramer information that was published over the last 6 months...it shows you exactly the worth of that information if you followed it. I remember seeing $13.00 as the price of this HZNP around the first of the year. After my DD, I had no problem staying with this wonderful investment. Here is what helped:
Geringerart / PB: I read all his offerings on this board going way back as the stock sat at $2 or less...I could interpret the honesty, consistency and quality of each message.
I then experience Mike's contributions and a wonderful sense of investment counseling. Some of it I knew and other times I soaked it in and applied it to my general knowledge.
I then notice these two attracted others with significant experience - offering excellent content and also asking very good questions.
Another key ingredient was TW - thank you Geringerart for the heads up and biography on him.
Consistency of TW: selecting quality products, unique to the market place, long patent lives, significant room for financial growth, great purchase points and a pattern of excellent financing resulting in quick payoff.
The future: The orphan drugs are unbelievable with significant capability for growth.
Incentive: TW (as Geringerat notes) has put the carrot out there for his management - you produce - you win big time - we all do!
Ireland: Tax advantage - unbelievable how this worked out!
Chicago: The new think-tank for small biotechs to come together that TW is on the board...as Geringerart noted - it's like shopping in a huge shopping mall of biotechs with products for sale.
So my question is: Has Zacks or Cramer produced or shared anything on this level to help us develop a sense of confidence?
I'm long HZNP - IMHO
I had to revisit this specific posting. I think we all know the value of some of the recommendations given out...they tend to be "Self Help" in that it is contrary to what will happen...14 days later - after Cramer says sell - and the gold mine produces again and again and again. For those that have done their DD with HZNP and are true longs...congratulations. For those trying to finish with their educations related to "Sell Side"...I hope you're finished and understand what is really behind it.
It is all within the context of the recommendation: Sell: maybe for a specific point and time but don't be out very long. IMHO
Why do I get that feeling that what Cramer said is tied to yesterday's 8 - K filling? More shares coming to the market (some dilution but for the good) so he times his monumental statement so as to hopefully reduce the share price for obvious reasons?
Ok, I'll go back on my psych meds.
Happy St. Patrick Day to everyone!
I would say that what you shared is a summary of the "Respect" that HZNP has earned from the financial / investment community over a short period of time. It amazes me the type of financing they now can acquire as compared to about 12 to 18 months ago. TW has certainly developed this company on a fast track and quality is not lacking.
As with anything else it has to start somewhere...in this case this is another potential indication for Actimmune but down the road. But, as you see the number of uses per month of Actimmune increasing from 1 - 3 now at 5 - 7, this could be part of the reason...what is considered "off label use". Horizon can't openly go out to the public and state that Actimmune potentially will work in Autosomal Dominant Osteopetrosis Type II (ADO2) diagnosed patient. This type of data will catch the eyes of those looking for a solution to a patient's illness that may be diagnosed as ADO2. To me this is actually very good news. We all are use to the explosive growth of this company yet all these type of studies someday will also add to the bottom line.
Hey, the good news is that the mice have one heck of a great orphan drug that works on them! Lot's of mice out there!!!
I too use to travel at a rapid pace and found the same out of body experiences. I one day discovered a solution: I simply woke in the morning, no matter what hotel, I would turn the light on and look at the address on the telephone. I knew right way where my body was!
Good luck and good fortune in your travels.
Sometimes I think of this investment this way (at this time - looking backwards):
1) If I gave someone $2 and they would give me $20 for each occurrence would I do it? It's been this way for over a year - yes the ratio of reward changes as the stock price climbs but those with patience have been consistently rewarded.
2) Has the leader of the company of interest shown any indication of not knowing what he / she is doing? In this case TW has been on target - yes a couple of bumps but what company doesn't have that. It's how you "Manage" these events. Also, think about where he developed this "Management" style - looking at his past is very compelling and deserving of what he has achieved. I see more to come.
3) Paying off acquisitions have been unbelievable. It's almost a crime how TW has acquired companies and then turned them into almost instant successes.
4) The protection of these assets are always of the utmost importance - long patent lives. Wow...the profits keep coming in and more to come.
5) You tell me what company has these attributes and especially in this business economy we are in?
6) You are never bored in this investment - I've learned how patience pays off - consistently.
7) It's amazing the support and leadership on this bored - this goes for all involved - we are all needed to survive this venture and we are very well.
As I said before with HZNP - If you want to see the future, look at the past.
I personally have no doubt TW is going to pull another rabbit out of his hat. When we look at "A", we can see already where that is going...a piece of coal that turned into a diamond almost over night. As noted in the latest CC - the number of patients going on "A" has moved from 1-3 / month or a 2 average to 5 - 7 or a 6 average. So it's moved from 2 to 6 patients per month at over a $400,000 per patient clip using old numbers...we know that price has changed too. Don't forget the huge potential of other indications and the current status the FDA gave "A".
We saw similar results with all the products TW has touched. You listen to the CC and TW's inflection and confidence is amazingly different at this point. Does he sound like let's say the CEO of ARNA? Absolutely not. TW is giving us constant laser specific guidance all along and it isn't delayed.
As always, I feel good about the next move and can't wait to hear about it. IMHO